Home › Funds › Andera Partners › KMTS
Andera Partners position in KMTS
KESTRA MEDICAL TECHNOLOGIES · Health Care
Andera Partners reported holding 2,728,679 shares of KMTS (KESTRA MEDICAL TECHNOLOGIES) in its Q3 2026 13F filing — a position valued at US$77.2M, representing 43.94% of its reported portfolio and ranking #1 among its reported holdings. Andera Partners has disclosed KMTS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-17 · Source: SEC EDGAR Form 13F-HR
How Andera Partners's KMTS position evolved
Andera Partners first disclosed a stake in KMTS in Q4 2025 at 2,540,106 shares (US$67.4M). The position peaked in Q3 2026 at 2,728,679 shares, worth US$77.2M. Across 4 filings, Andera Partners increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,728,679 shares valued at US$77.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 2.54M | $67.36M | New |
| Q1 2026 | 2.70M | $53.72M | Add |
| Q2 2026 | 2.73M | $69.42M | Add |
| Q3 2026 | 2.73M | $77.19M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KMTS and 13F data
KMTS (KESTRA MEDICAL TECHNOLOGIES) is a Health Care company. 70 other funds we track also report a position in KMTS — the largest reported positions include BAIN CAPITAL INVESTORS LLC (US$640.4M), Yu Fan (US$58.1M), Omega Fund Management, LLC (US$26.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KMTS
- BAIN CAPITAL INVESTORS LLC 25.17M sh · $640.38M · Q2 2026
- Yu Fan 2.28M sh · $58.07M · Q2 2026
- Omega Fund Management, LLC 1.02M sh · $26.00M · Q2 2026
More on Andera Partners
FAQ
How long has Andera Partners held KMTS?
Andera Partners has disclosed KMTS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Andera Partners's current position in KMTS?
As of Q3 2026, Andera Partners holds 2.73M shares of KMTS (KESTRA MEDICAL TECHNOLOGIES), valued at $77.19M, representing 43.94% of its reported portfolio and ranking #1.
Has Andera Partners been buying or selling KMTS?
In the latest 13F filing (Q3 2026), Andera Partners held unchanged its position in KMTS. The position peaked in Q3 2026 at 2.73M shares.
Which other funds hold KMTS?
Other major institutional holders of KMTS include BAIN CAPITAL INVESTORS LLC, Yu Fan, Omega Fund Management, LLC, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.